Literature DB >> 33084192

Assessing physical symptoms, daily functioning, and well-being in children with achondroplasia.

Kathryn M Pfeiffer1, Meryl Brod1, Alden Smith2, Jill Gianettoni3, Dorthe Viuff4, Sho Ota5, R Will Charlton5.   

Abstract

This study's purpose was to provide qualitative evidence to support the development of two observer-reported outcome measures assessing the physical symptoms/complications of achondroplasia in children and impacts on children's quality of life. Individual/focus group concept elicitation interviews were conducted with parents of children aged 2 to <12 years with achondroplasia and experts. Qualitative analysis of transcripts, based on an adapted grounded theory approach, informed item generation and measure development. Cognitive debriefing (CD) interviews were conducted with parents to confirm relevance and understanding. Thirty-six parents participated in concept elicitation interviews. The analysis identified major physical symptoms/complications and impacts of achondroplasia, which informed the development of the Achondroplasia Child Experience Measures (ACEMs): ACEM-Symptom and ACEM-Impact. ACEM-Symptom was comprised of eight major symptoms/complications including pain (58%), ear infections/fluid in ear (56%), and low stamina/tiring easily (56%). ACEM-Impact consisted of 31 major impacts in the domains of daily functioning, emotional well-being, social well-being, and need for assistance/adaptive devices. Impacts on functioning included difficulty reaching objects/high places (89%) and toileting (67%). Emotional impacts included feeling different (53%) and feeling frustrated/annoyed (47%). Social impacts included difficulty participating in sports/physical play (86%) and being treated as younger than age (83%). Following CD interviews with 16 additional parents, validation-ready ACEM measures were generated. The study improves our understanding of the experiences of children with achondroplasia and provides evidence supporting the content validity of the ACEMs. Validated ACEMs may be used to assess potential benefits of future treatments for comorbidities of achondroplasia.
© 2020 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.

Entities:  

Keywords:  achondroplasia; emotional well-being; observer-reported outcome measure; physical functioning; quality of life; social well-being

Mesh:

Year:  2020        PMID: 33084192      PMCID: PMC7756853          DOI: 10.1002/ajmg.a.61903

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  26 in total

1.  Living with achondroplasia in an average-sized world: an assessment of quality of life.

Authors:  Sarah E Gollust; Richard E Thompson; Holly C Gooding; Barbara B Biesecker
Journal:  Am J Med Genet A       Date:  2003-08-01       Impact factor: 2.802

2.  Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding.

Authors:  Donald L Patrick; Laurie B Burke; Chad J Gwaltney; Nancy Kline Leidy; Mona L Martin; Elizabeth Molsen; Lena Ring
Journal:  Value Health       Date:  2011-10-10       Impact factor: 5.725

3.  Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument.

Authors:  Donald L Patrick; Laurie B Burke; Chad J Gwaltney; Nancy Kline Leidy; Mona L Martin; Elizabeth Molsen; Lena Ring
Journal:  Value Health       Date:  2011-10-13       Impact factor: 5.725

4.  C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia.

Authors:  Ravi Savarirayan; Melita Irving; Carlos A Bacino; Bret Bostwick; Joel Charrow; Valerie Cormier-Daire; Kim-Hanh Le Quan Sang; Patricia Dickson; Paul Harmatz; John Phillips; Natalie Owen; Anu Cherukuri; Kala Jayaram; George S Jeha; Kevin Larimore; Ming-Liang Chan; Alice Huntsman Labed; Jonathan Day; Julie Hoover-Fong
Journal:  N Engl J Med       Date:  2019-06-18       Impact factor: 91.245

5.  Qualitative research and content validity: developing best practices based on science and experience.

Authors:  Meryl Brod; Laura E Tesler; Torsten L Christensen
Journal:  Qual Life Res       Date:  2009-09-27       Impact factor: 4.147

6.  Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force.

Authors:  Louis S Matza; Donald L Patrick; Anne W Riley; John J Alexander; Luis Rajmil; Andreas M Pleil; Monika Bullinger
Journal:  Value Health       Date:  2013-06       Impact factor: 5.725

Review 7.  Parent-child agreement across child health-related quality of life instruments: a review of the literature.

Authors:  Penney Upton; Joanne Lawford; Christine Eiser
Journal:  Qual Life Res       Date:  2008-06-03       Impact factor: 4.147

Review 8.  Current Care and Investigational Therapies in Achondroplasia.

Authors:  Sheila Unger; Luisa Bonafé; Elvire Gouze
Journal:  Curr Osteoporos Rep       Date:  2017-04       Impact factor: 5.096

9.  Quality of life of children with achondroplasia and their parents - a German cross-sectional study.

Authors:  Stefanie Witt; Beate Kolb; Janika Bloemeke; Klaus Mohnike; Monika Bullinger; Julia Quitmann
Journal:  Orphanet J Rare Dis       Date:  2019-08-09       Impact factor: 4.123

10.  Assessing physical symptoms, daily functioning, and well-being in children with achondroplasia.

Authors:  Kathryn M Pfeiffer; Meryl Brod; Alden Smith; Jill Gianettoni; Dorthe Viuff; Sho Ota; R Will Charlton
Journal:  Am J Med Genet A       Date:  2020-10-20       Impact factor: 2.802

View more
  7 in total

1.  Outpatient Clinic in Ancient Greece.

Authors:  George Samonis; Christos Koutserimpas; Maria-Ioanna Rantou; Marianna Karamanou; Manolis I Stefanakis
Journal:  Maedica (Bucur)       Date:  2021-12

2.  Treatment Goals for Achondroplasia: A Qualitative Study with Parents and Adults.

Authors:  Sarah A McGraw; Jeff C Henne; James Nutter; Adelpha Abrahamson Larkin; Er Chen
Journal:  Adv Ther       Date:  2022-06-08       Impact factor: 4.070

3.  Experiences of children and adolescents living with achondroplasia and their caregivers.

Authors:  Renée Shediac; Olga Moshkovich; Heather Gerould; Rachel Ballinger; Agnes Williams; M Alex Bellenger; Jennifer Quinn; Julie Hoover-Fong; Klaus Mohnike; Ravi Savarirayan; Dominique Kelly
Journal:  Mol Genet Genomic Med       Date:  2022-02-09       Impact factor: 2.183

4.  Functioning and well-being in older children and adolescents with achondroplasia: A qualitative study.

Authors:  Kathryn M Pfeiffer; Meryl Brod; Alden Smith; Dorthe Viuff; Sho Ota; R Will Charlton
Journal:  Am J Med Genet A       Date:  2021-10-13       Impact factor: 2.578

5.  Assessing physical symptoms, daily functioning, and well-being in children with achondroplasia.

Authors:  Kathryn M Pfeiffer; Meryl Brod; Alden Smith; Jill Gianettoni; Dorthe Viuff; Sho Ota; R Will Charlton
Journal:  Am J Med Genet A       Date:  2020-10-20       Impact factor: 2.802

Review 6.  Advantages and Disadvantages of Different Treatment Methods in Achondroplasia: A Review.

Authors:  Wiktoria Wrobel; Emilia Pach; Iwona Ben-Skowronek
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

7.  The first European consensus on principles of management for achondroplasia.

Authors:  Valerie Cormier-Daire; Moeenaldeen AlSayed; Tawfeg Ben-Omran; Sérgio Bernardo de Sousa; Silvio Boero; Svein O Fredwall; Encarna Guillen-Navarro; Melita Irving; Christian Lampe; Mohamad Maghnie; Geert Mortier; Zagorka Peijin; Klaus Mohnike
Journal:  Orphanet J Rare Dis       Date:  2021-07-31       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.